Vaginal Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Vaginal Carcinoma

subtype

Identifier: CI-CAN-00007052
Entity page: /cancer/vaginal-carcinoma ↗
Edges: 37

Neighbours: 10 drugs10 trials
Drawn: 20 of 20 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Vaginal Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived10 of 10
→ investigated in trials for	Cisplatinsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Vaginal Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—

Vaginal Carcinoma studied in …STUDIED_INderived10 of 27show all (up to 200)
→ studied in	NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped CURATED_BROADER · 27 trials mapped (17 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00791635active not recruiting Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer · condition mapped ONTOLOGY_EXACT · 27 trials mapped (17 active)	—	—	Vaginal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 27 trials mapped (17 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07804966Phase 2 · not yet recruiting Sac-TMT in Vaginal and Vulvar Cancers · condition mapped CURATED_BROADER · 27 trials mapped (17 active)	—	—	Vaginal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02466971Phase 3 · active not recruiting Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers · condition mapped CURATED_BROADER · 27 trials mapped (17 active)	—	—	Vaginal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02595879Phase 1 · active not recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer · condition mapped CURATED_BROADER · 27 trials mapped (17 active)	—	—	Vaginal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03180294Phase 2 · completed Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer · condition mapped ONTOLOGY_EXACT · 27 trials mapped (17 active)	—	—	Vaginal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 27 trials mapped (17 active)	—	—	Vaginal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 27 trials mapped (17 active)	—	—	Vaginal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 27 trials mapped (17 active)	—	—	Human Papillomavirus-Related Vaginal Adenocarcinoma	1	Observed	clinicaltrials	graph →